WELLS FARGO & COMPANY/MN - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 133 filers reported holding CTI BIOPHARMA CORP in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$870,534
+1924.5%
207,270
+2691.1%
0.00%
Q3 2022$43,000
+22.9%
7,426
+26.9%
0.00%
Q2 2022$35,000
+1650.0%
5,851
+1070.2%
0.00%
Q1 2022$2,000
+100.0%
500
-3.3%
0.00%
Q4 2021$1,000
-50.0%
517
+0.2%
0.00%
Q3 2021$2,000
+100.0%
516
-5.0%
0.00%
Q2 2021$1,0000.0%543
+44.0%
0.00%
Q1 2021$1,000
-99.4%
377
-99.2%
0.00%
Q4 2020$157,000
+15600.0%
48,910
+13954.6%
0.00%
Q3 2020$1,0000.0%348
-42.8%
0.00%
Q2 2020$1,000608
+35.1%
0.00%
Q1 2020$0
-100.0%
450
-81.4%
0.00%
Q2 2019$2,000
-98.6%
2,425
-98.3%
0.00%
Q1 2019$138,000
+20.0%
143,099
-9.0%
0.00%
Q4 2018$115,000
-2.5%
157,169
+188.0%
0.00%
Q3 2018$118,000
-55.5%
54,564
+2.5%
0.00%
Q2 2018$265,000
+138.7%
53,229
+88.3%
0.00%
Q1 2018$111,000
+48.0%
28,263
+0.8%
0.00%
Q4 2017$75,00028,032
+121778.3%
0.00%
Q2 2017$023
-8.0%
0.00%
Q1 2017$0250.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 6,535,674$27,449,8319.21%
Bleichroeder LP 3,893,730$16,353,6663.49%
AIGH Capital Management LLC 2,100,000$8,820,0003.25%
Ally Bridge Group (NY) LLC 550,000$2,310,0003.03%
Ghost Tree Capital, LLC 2,000,000$8,400,0002.48%
Bain Capital Life Sciences Investors, LLC 4,702,996$19,7532.47%
Altium Capital Management LP 850,000$3,570,0001.98%
Parkman Healthcare Partners LLC 1,753,630$7,365,2461.60%
BVF INC/IL 8,813,021$37,014,6881.35%
Sio Capital Management, LLC 526,239$2,210,2041.09%
View complete list of CTI BIOPHARMA CORP shareholders